Titan Pharmaceuticals, Inc. common stock (TTNP) is lower by -6.36% in a Week, Should You Buy?

Wednesday, October 12, 2022 01:24 PM | InvestorsObserver Analysts

Mentioned in this article

Titan Pharmaceuticals, Inc. common stock (TTNP) is lower by -6.36% in a Week, Should You Buy?

Titan Pharmaceuticals, Inc. common stock (TTNP) is around the middle of the Biotechnology industry according to InvestorsObserver. TTNP received an overall rating of 47, which means that it scores higher than 47 percent of all stocks. Titan Pharmaceuticals, Inc. common stock also achieved a score of 38 in the Biotechnology industry, putting it above 38 percent of Biotechnology stocks. Biotechnology is ranked 14 out of the 148 industries.

TTNP has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on TTNP!

See Full TTNP Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Titan Pharmaceuticals, Inc. common stock Stock Today?

Titan Pharmaceuticals, Inc. common stock (TTNP) stock is trading at $1.03 as of 12:49 PM on Wednesday, Oct 12, an increase of $0.03, or 3% from the previous closing price of $1.00. The stock has traded between $0.99 and $1.05 so far today. Volume today is light. So far 20,939 shares have traded compared to average volume of 42,432 shares. Click Here to get the full Stock Report for Titan Pharmaceuticals, Inc. common stock stock.